196 related articles for article (PubMed ID: 10914715)
1. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis.
Hidaka S; Yasutake T; Takeshita H; Kondo M; Tsuji T; Nanashima A; Sawai T; Yamaguchi H; Nakagoe T; Ayabe H; Tagawa Y
Clin Cancer Res; 2000 Jul; 6(7):2712-7. PubMed ID: 10914715
[TBL] [Abstract][Full Text] [Related]
2. Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy.
Nakao K; Shibusawa M; Ishihara A; Yoshizawa H; Tsunoda A; Kusano M; Kurose A; Makita T; Sasaki K
Cancer; 2001 Feb; 91(4):721-6. PubMed ID: 11241239
[TBL] [Abstract][Full Text] [Related]
3. Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma.
Yamamoto S; Midorikawa Y; Morikawa T; Nishimura Y; Sakamoto H; Ishikawa S; Akagi K; Aburatani H
Genes Chromosomes Cancer; 2010 May; 49(5):487-96. PubMed ID: 20175194
[TBL] [Abstract][Full Text] [Related]
4. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.
Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA
Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis.
Aust DE; Muders M; Köhler A; Schmidt M; Diebold J; Müller C; Löhrs U; Waldman FM; Baretton GB
Scand J Gastroenterol; 2004 Aug; 39(8):766-72. PubMed ID: 15513363
[TBL] [Abstract][Full Text] [Related]
6. Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis.
Sayagués JM; Abad Mdel M; Melchor HB; Gutiérrez ML; González-González M; Jensen E; Bengoechea O; Fonseca E; Orfao A; Muñoz-Bellvis L
J Pathol; 2010 Jul; 221(3):308-19. PubMed ID: 20527024
[TBL] [Abstract][Full Text] [Related]
7. PRL-3 expression in metastatic cancers.
Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
[TBL] [Abstract][Full Text] [Related]
8. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis.
Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278
[TBL] [Abstract][Full Text] [Related]
9. Detection of 20q13 gain by dual-color FISH in breast cancers.
Kobayashi Y; Esato K; Noshima S; Oga A; Sasaki K
Anticancer Res; 2000; 20(1B):531-5. PubMed ID: 10769720
[TBL] [Abstract][Full Text] [Related]
10. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.
Tanner MM; Tirkkonen M; Kallioniemi A; Holli K; Collins C; Kowbel D; Gray JW; Kallioniemi OP; Isola J
Clin Cancer Res; 1995 Dec; 1(12):1455-61. PubMed ID: 9815944
[TBL] [Abstract][Full Text] [Related]
11. The candidate oncogene ZNF217 is frequently amplified in colon cancer.
Rooney PH; Boonsong A; McFadyen MC; McLeod HL; Cassidy J; Curran S; Murray GI
J Pathol; 2004 Nov; 204(3):282-8. PubMed ID: 15476264
[TBL] [Abstract][Full Text] [Related]
12. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes.
Tanner MM; Tirkkonen M; Kallioniemi A; Collins C; Stokke T; Karhu R; Kowbel D; Shadravan F; Hintz M; Kuo WL
Cancer Res; 1994 Aug; 54(16):4257-60. PubMed ID: 8044767
[TBL] [Abstract][Full Text] [Related]
13. [Occurrence of numerical aberrations of chromosomes in metachronous liver metastases of colorectal cancers].
Kawai K; Ueda K; Ochiai T; Ogino A; Konishi E; Urata Y; Itoi H; Yamagishi H; Oka T; Ashihara T
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():174-81. PubMed ID: 8678564
[TBL] [Abstract][Full Text] [Related]
14. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
15. Prognosis and gene expression profiling of 20q13-amplified breast cancers.
Ginestier C; Cervera N; Finetti P; Esteyries S; Esterni B; Adélaïde J; Xerri L; Viens P; Jacquemier J; Charafe-Jauffret E; Chaffanet M; Birnbaum D; Bertucci F
Clin Cancer Res; 2006 Aug; 12(15):4533-44. PubMed ID: 16899599
[TBL] [Abstract][Full Text] [Related]
16. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
Gong Y; Booser DJ; Sneige N
Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
[TBL] [Abstract][Full Text] [Related]
17. The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes.
Diep CB; Kleivi K; Ribeiro FR; Teixeira MR; Lindgjaerde OC; Lothe RA
Genes Chromosomes Cancer; 2006 Jan; 45(1):31-41. PubMed ID: 16145679
[TBL] [Abstract][Full Text] [Related]
18. Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma.
Koynova DK; Jordanova ES; Milev AD; Dijkman R; Kirov KS; Toncheva DI; Gruis NA
Melanoma Res; 2007 Feb; 17(1):37-41. PubMed ID: 17235240
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
[TBL] [Abstract][Full Text] [Related]
20. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization.
Weiss MM; Snijders AM; Kuipers EJ; Ylstra B; Pinkel D; Meuwissen SG; van Diest PJ; Albertson DG; Meijer GA
J Pathol; 2003 Jul; 200(3):320-6. PubMed ID: 12845628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
